Evidence map›Paper›PMID 42512390›Full record

ArticleCancers2026

Prognostic Value of Morphological Characteristics and Immune Microenvironment in High-Grade Serous Cancer (HGSC).

Danijel Antonio Grubišić, Branka Petrić Miše, Toni Čeprnja, Vesna Telesmanić Dobrić, Vesna Čapkun, Snježana Tomić

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Danijel Antonio GrubišićDepartment of Pathology, Forensic Medicine and Cytology, University Hospital Centre Split, 21000 Split, Croatia.
Branka Petrić MišeDepartment of Pathology, School of Medicine, University of Split, 21000 Split, Croatia.
Toni ČeprnjaDepartment of Pathology, Forensic Medicine and Cytology, University Hospital Centre Split, 21000 Split, Croatia.
Vesna Telesmanić DobrićDepartment of Oncology and Nuclear Medicine, Zadar General Hospital, 23000 Zadar, Croatia.
Vesna ČapkunDepartment of Nuclear Medicine, University Hospital Centre Split, School of Medicine, University of Split, 21000 Split, Croatia.
Snježana TomićDepartment of Pathology, Forensic Medicine and Cytology, University Hospital Centre Split, 21000 Split, Croatia.ORCID 0009-0003-3779-0712

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CD8-positive lymphocyteshigh-grade serous ovarian cancerimmunophenotypelymphoid aggregatesovarian cancer immunologyPD-L1progression-free survivalSET morphologytumor-infiltrating lymphocytestumor microenvironment

Identifiers

PMID42512390
PMCPMC13406278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.